Independent studies demonstrated that genotype C patients seroconvert from HBeAg to anti-HBe about 10 years later than genotype B patients, and, consequently, the prolonged active viral DNA replication and protein expression increase the lifelong risk for liver cirrhosis and HCC [7,8,9,10,11,12]. Here, HBE1 is linked to hepatocellular carcinoma.